<!DOCTYPE html>

<html lang="en" data-theme="light">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Histamine and Antihistaminics - Essentials of Medical Pharmacology</title>
<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">

<link rel="stylesheet" href="../styles/main.css">

<script>
MathJax = {
    tex: {
        inlineMath: [['$', '$'], ['\\(', '\\)']],
        displayMath: [['$$', '$$'], ['\\[', '\\]']],
        processEscapes: true,
        processEnvironments: true
    },
    svg: { fontCache: 'global' },
    options: {
        skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
    }
};
</script>
<script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
<a href="#main-content" class="skip-link">Skip to main content</a>
<button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
    <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
    <span class="theme-toggle-icon dark-icon">üåô</span>
</button>

<div class="reading-progress-container">
    <div class="reading-progress-bar" id="reading-progress"></div>
</div>

<!-- Floating TOC -->
<nav class="floating-toc" id="floating-toc">
    <div class="floating-toc-header">
        <span>üìë</span> Table of Contents
    </div>
    <ul class="floating-toc-list">
        <li><a href="#histamine">Histamine</a></li>
        <li><a href="#receptors">Histamine Receptors</a></li>
        <li><a href="#actions">Pharmacological Actions</a></li>
        <li><a href="#pathophysiology">Pathophysiological Roles</a></li>
        <li><a href="#h1-antagonists">H1 Antagonists</a></li>
        <li><a href="#second-gen">Second Generation Antihistaminics</a></li>
        <li><a href="#uses">Therapeutic Uses</a></li>
        <li><a href="#problem-study">Problem Directed Study</a></li>
    </ul>
</nav>

<div class="page-wrapper">
    <div class="container">
        <article class="document-article">
            <header class="document-header">
                <div class="header-badge">
                    <span>ü§ß</span>
                    <span>Topic 12</span>
                </div>
                <h1 class="document-title">Histamine and Antihistaminics</h1>
                <div class="title-meta">
                    <div class="meta-item">
                        <span>üìö</span>
                        <span>Autacoids and Related Drugs</span>
                    </div>
                    <div class="meta-item">
                        <span>‚è±Ô∏è</span>
                        <span>35 min read</span>
                    </div>
                </div>
            </header>

            <main id="main-content" class="content-wrapper">
                <!-- Section 1: Histamine Introduction -->
                <section class="content-section" id="histamine">
                    <div class="section-header">
                        <div class="section-number">01</div>
                        <h2 class="section-title">
                            <span class="title-icon">üß¨</span>
                            Histamine
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>Histamine, meaning 'tissue amine' (<em>histos</em>‚Äîtissue) is almost ubiquitously present in animal tissues and in certain plants, e.g. stinging nettle. Histamine is present mostly within storage granules of mast cells. Tissues rich in histamine are skin, gastric and intestinal mucosa, lungs, liver and placenta. Nonmast cell histamine occurs in brain, epidermis, gastric mucosa and growing regions. Turnover of mast cell histamine is slow, while that of nonmast cell histamine is fast.</p>

                        <h3>Synthesis, Storage and Destruction</h3>
                        <p>Histamine is $\beta$-imidazolylethylamine. It is synthesized locally from the amino acid histidine and degraded rapidly by oxidation and methylation.</p>
                        
                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../assets/images/image-20251214-6511f31a.jpeg" alt="Synthesis and degradation of histamine" class="figure-image">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption">Fig. 11.1: Synthesis and degradation of histamine. MAO‚ÄîMonoamine oxidase.</figcaption>
                        </figure>

                        <p>In mast cells, histamine (positively charged) is held by an acidic protein and heparin (negatively charged) within intracellular granules. When the granules are extruded by exocytosis, $\mathrm{Na}^{+}$ ions in e.c.f. exchange with histamine to release it free. Increase in intracellular cAMP (caused by $\beta$ adrenergic agonists and methylxanthines) inhibits histamine release. Histamine is inactive orally because liver degrades all histamine that is absorbed from the intestines.</p>

                        <h3>Histamine Releasers</h3>
                        <p>A variety of mechanical, chemical and immunological stimuli are capable of releasing histamine from mast cells.</p>
                        <ul class="enhanced-list">
                            <li class="list-item"><strong>Tissue damage:</strong> trauma, stings and venoms, proteolytic enzymes, phospholipase A.</li>
                            <li class="list-item"><strong>Antigen: antibody reaction</strong> involving IgE antibodies.</li>
                            <li class="list-item"><strong>Polymers:</strong> dextran, polyvinyl pyrrolidone (PVP).</li>
                            <li class="list-item"><strong>Basic drugs:</strong> tubocurarine, morphine, atropine, pentamidine, polymyxin B, vancomycin and even some antihistaminics release histamine by displacing it from the binding site.</li>
                            <li class="list-item"><strong>Surface acting agents:</strong> Tween 80, compound 48/80.</li>
                        </ul>
                    </div>
                </section>

                <!-- Section 2: Receptors -->
                <section class="content-section" id="receptors">
                    <div class="section-header">
                        <div class="section-number">02</div>
                        <h2 class="section-title">
                            <span class="title-icon">üì°</span>
                            Histamine Receptors
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>Four types of histaminergic receptors have now been clearly delineated and cloned.</p>
                        
                        <div class="table-responsive">
                            <table class="comparison-table">
                                <thead>
                                    <tr>
                                        <th>Feature</th>
                                        <th>$\mathbf{H_1}$</th>
                                        <th>$\mathbf{H_2}$</th>
                                        <th>$\mathbf{H_3}$</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>Selective Agonist</strong></td>
                                        <td>2-Methyl histamine</td>
                                        <td>Dimaprit, Impromidine</td>
                                        <td>(R) $\alpha$-Methyl histamine</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Selective Antagonist</strong></td>
                                        <td>Mepyramine, Chlorpheniramine</td>
                                        <td>Cimetidine, Ranitidine</td>
                                        <td>Thioperamide</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Receptor Type</strong></td>
                                        <td>Gq-protein coupled</td>
                                        <td>Gs-protein coupled</td>
                                        <td>Gi/Go-protein coupled</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Effector Pathway</strong></td>
                                        <td>$IP_3/DAG \uparrow$, cytosolic $Ca^{2+} \uparrow$</td>
                                        <td>cAMP $\uparrow$</td>
                                        <td>$Ca^{2+}$ influx $\downarrow$</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Distribution & Function</strong></td>
                                        <td>
                                            <strong>Smooth muscle:</strong> contraction<br>
                                            <strong>Endothelium:</strong> NO release<br>
                                            <strong>Nerve endings:</strong> pain, itch<br>
                                            <strong>Brain:</strong> wakefulness
                                        </td>
                                        <td>
                                            <strong>Gastric glands:</strong> acid secretion<br>
                                            <strong>Heart:</strong> rate/force $\uparrow$<br>
                                            <strong>Uterus:</strong> relaxation
                                        </td>
                                        <td>
                                            <strong>Brain (presynaptic):</strong> inhibition of histamine release<br>
                                            <strong>Nerves:</strong> heteroreceptor inhibition
                                        </td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>

                        <div class="callout callout--note">
                            <div class="callout-header">
                                <span class="callout-icon">üí°</span>
                                <h4 class="callout-title">H4 Receptor</h4>
                            </div>
                            <div class="callout-content">
                                <p>A fourth receptor ($\mathrm{H}_{4}$) has been identified. It has considerable homology with $\mathrm{H}_{3}$ receptor. Eosinophils, mast cells and basophils are the primary cells expressing $\mathrm{H}_{4}$ receptors. Activation enhances chemotaxis of these cells, suggesting a role in allergic inflammation.</p>
                            </div>
                        </div>
                    </div>
                </section>

                <!-- Section 3: Pharmacological Actions -->
                <section class="content-section" id="actions">
                    <div class="section-header">
                        <div class="section-number">03</div>
                        <h2 class="section-title">
                            <span class="title-icon">‚öôÔ∏è</span>
                            Pharmacological Actions
                        </h2>
                    </div>

                    <div class="content-card">
                        <h4>1. Blood vessels</h4>
                        <p>Histamine causes marked dilatation of smaller blood vessels, including arterioles, capillaries and venules. Rapid i.v. injection causes fall in BP which has an early short lasting $\mathrm{H}_{1}$ and a slow but more persistent $\mathrm{H}_{2}$ component. Vasodilatation is partly indirect, mediated through 'endothelium dependent relaxing factor' (EDRF), i.e. NO ($\mathrm{H}_{1}$). $\mathrm{H}_{2}$ receptors mediating vasodilatation are located directly on the vascular smooth muscle. Larger arteries and veins are constricted ($\mathrm{H}_{1}$).</p>
                        <p>Histamine also causes increased capillary permeability due to separation of endothelial cells resulting in exudation of plasma ($\mathrm{H}_{1}$).</p>

                        <div class="callout callout--info">
                            <div class="callout-header">
                                <span class="callout-icon">üî¥</span>
                                <h4 class="callout-title">Triple Response</h4>
                            </div>
                            <div class="callout-content">
                                <p>Injected intradermally, histamine elicits:</p>
                                <ol>
                                    <li><strong>Red spot:</strong> due to intense capillary dilatation.</li>
                                    <li><strong>Wheal:</strong> due to exudation of fluid from capillaries and venules.</li>
                                    <li><strong>Flare:</strong> redness in the surrounding area due to arteriolar dilatation mediated by axon reflex.</li>
                                </ol>
                            </div>
                        </div>

                        <h4>2. Heart</h4>
                        <p>Direct effects are not prominent in situ, but isolated heart is stimulated ($\mathrm{H}_{2}$).</p>

                        <h4>3. Visceral smooth muscle</h4>
                        <p>Histamine causes bronchoconstriction ($\mathrm{H}_{1}$); guinea pigs and patients of asthma are highly sensitive. Large doses cause abdominal cramps and colic.</p>

                        <h4>4. Glands</h4>
                        <p>Histamine causes marked increase in gastric secretion‚Äîprimarily of acid but also of pepsin. This is a direct action exerted on parietal cells through $\mathrm{H}_{2}$ receptors, mediated by cAMP.</p>

                        <h4>5. Sensory nerve endings</h4>
                        <p>Itching and pain occur when histamine is injected i.v. or intracutaneously ($\mathrm{H}_{1}$).</p>

                        <h4>6. CNS</h4>
                        <p>Histamine does not penetrate blood-brain barrier. However, intracerebroventricular administration produces rise in BP, cardiac stimulation, behavioural arousal, hypothermia, vomiting and ADH release.</p>
                    </div>
                </section>

                <!-- Section 4: Pathophysiological Roles -->
                <section class="content-section" id="pathophysiology">
                    <div class="section-header">
                        <div class="section-number">04</div>
                        <h2 class="section-title">
                            <span class="title-icon">ü©∫</span>
                            Pathophysiological Roles
                        </h2>
                    </div>

                    <div class="content-card">
                        <ul class="enhanced-list">
                            <li class="list-item"><strong>Gastric secretion:</strong> Histamine has dominant physiological role in mediating secretion of HCl. It acts synergistically with ACh and gastrin.</li>
                            <li class="list-item"><strong>Allergic phenomena:</strong> Released from mast cells in immediate type hypersensitivity (Type I) reactions. Causative in urticaria, angioedema, bronchoconstriction and anaphylactic shock.</li>
                            <li class="list-item"><strong>Transmitter:</strong> Afferent transmitter for itch and pain. Nonmast cell histamine in brain is involved in maintaining wakefulness ($\mathrm{H}_{1}$), suppressing appetite, regulating body temperature and thirst.</li>
                            <li class="list-item"><strong>Inflammation:</strong> Mediator of vasodilatation and edema. Promotes adhesion of leukocytes.</li>
                            <li class="list-item"><strong>Tissue growth and repair:</strong> High concentrations in growing tissues.</li>
                            <li class="list-item"><strong>Headache:</strong> Implicated in vascular headaches.</li>
                        </ul>
                    </div>
                </section>

                <!-- Section 5: H1 Antagonists -->
                <section class="content-section" id="h1-antagonists">
                    <div class="section-header">
                        <div class="section-number">05</div>
                        <h2 class="section-title">
                            <span class="title-icon">üíä</span>
                            H1 Antagonists (Conventional)
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>These drugs competitively antagonize actions of histamine at the $\mathrm{H}_{1}$ receptors. Conventional antihistaminics have diverse chemical structures and often possess additional properties like sedative and anticholinergic effects.</p>

                        <div class="table-responsive">
                            <table class="comparison-table">
                                <thead>
                                    <tr>
                                        <th>Group</th>
                                        <th>Drug</th>
                                        <th>Dose</th>
                                        <th>Sedative</th>
                                        <th>Anticholinergic</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>Highly Sedative</strong></td>
                                        <td>Diphenhydramine</td>
                                        <td>25-50 mg oral</td>
                                        <td>+++</td>
                                        <td>High</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Dimenhydrinate</td>
                                        <td>25-50 mg oral</td>
                                        <td>+++</td>
                                        <td>High</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Promethazine</td>
                                        <td>25-50 mg oral/i.m.</td>
                                        <td>+++</td>
                                        <td>High</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Hydroxyzine</td>
                                        <td>25-50 mg oral/i.m.</td>
                                        <td>+++</td>
                                        <td>-</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Moderately Sedative</strong></td>
                                        <td>Pheniramine</td>
                                        <td>20-50 mg oral/i.m.</td>
                                        <td>++</td>
                                        <td>High</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Cyproheptadine</td>
                                        <td>4 mg oral</td>
                                        <td>++</td>
                                        <td>Low</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Meclozine</td>
                                        <td>25-50 mg oral</td>
                                        <td>++</td>
                                        <td>Low</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Cinnarizine</td>
                                        <td>25-50 mg oral</td>
                                        <td>++</td>
                                        <td>Low</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Mild Sedative</strong></td>
                                        <td>Chlorpheniramine</td>
                                        <td>2-4 mg oral/i.m.</td>
                                        <td>+</td>
                                        <td>Low</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Triprolidine</td>
                                        <td>2.5-5 mg oral</td>
                                        <td>+</td>
                                        <td>Low</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>

                        <h3>Pharmacological Actions</h3>
                        <ol class="enhanced-list">
                            <li class="list-item"><strong>Antagonism of histamine:</strong> Effectively block bronchoconstriction, contraction of intestinal muscle, and triple response (wheal, flare, itch). Fall in BP is only partially blocked.</li>
                            <li class="list-item"><strong>Antiallergic action:</strong> Control urticaria, itching, angioedema. Asthma is practically unaffected.</li>
                            <li class="list-item"><strong>CNS:</strong> Variable degree of CNS depression (sedation, diminished alertness). Some are effective in motion sickness (Promethazine, Diphenhydramine) and parkinsonism. Cyproheptadine stimulates appetite.</li>
                            <li class="list-item"><strong>Anticholinergic action:</strong> Many have atropine-like actions (dry mouth, urinary hesitancy).</li>
                            <li class="list-item"><strong>Local anaesthetic:</strong> Membrane stabilizing property (Pheniramine, Promethazine).</li>
                        </ol>

                        <h3>Side Effects and Toxicity</h3>
                        <ul>
                            <li><strong>Sedation:</strong> Diminished alertness, motor incoordination. Potentiate alcohol.</li>
                            <li><strong>Anticholinergic:</strong> Dryness of mouth, blurred vision, urinary hesitancy, constipation.</li>
                            <li><strong>GI:</strong> Epigastric distress.</li>
                            <li><strong>Acute overdose:</strong> Central excitation, tremors, hallucinations, convulsions, fever, cardiovascular failure.</li>
                        </ul>
                    </div>
                </section>

                <!-- Section 6: Second Generation Antihistaminics -->
                <section class="content-section" id="second-gen">
                    <div class="section-header">
                        <div class="section-number">06</div>
                        <h2 class="section-title">
                            <span class="title-icon">üÜï</span>
                            Second Generation Antihistaminics
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>Marketed after 1980, these have:</p>
                        <ul>
                            <li>Absence of CNS depressant property (poor BBB penetration).</li>
                            <li>Higher $\mathrm{H}_{1}$ selectivity (no anticholinergic side effects).</li>
                            <li>Additional antiallergic mechanisms (inhibit late phase mediators like leukotrienes, PAF).</li>
                        </ul>
                        <p>They do not impair psychomotor performance or sleep.</p>

                        <div class="grid grid-2">
                            <div class="grid-item">
                                <h4>Fexofenadine</h4>
                                <p>Active metabolite of terfenadine. Does not block cardiac $K^+$ channels (no Torsades de pointes). Minimally metabolized. $t_{1/2}$ 11-16 hr.<br><strong>Dose:</strong> 120-180 mg OD.</p>
                            </div>
                            <div class="grid-item">
                                <h4>Loratadine</h4>
                                <p>Long-acting, fast acting. Metabolized by CYP3A4. No cardiac arrhythmia reported.<br><strong>Dose:</strong> 10 mg OD.</p>
                            </div>
                            <div class="grid-item">
                                <h4>Desloratadine</h4>
                                <p>Active metabolite of loratadine. Effective at half dose (5 mg OD).</p>
                            </div>
                            <div class="grid-item">
                                <h4>Cetirizine</h4>
                                <p>Metabolite of hydroxyzine. Penetrates brain poorly but mild sedation possible. Inhibits eosinophil chemotaxis. $t_{1/2}$ 7-10 hr.<br><strong>Dose:</strong> 10 mg OD.</p>
                            </div>
                            <div class="grid-item">
                                <h4>Levocetirizine</h4>
                                <p>Active $R(-)$ enantiomer of cetirizine. Less sedation.<br><strong>Dose:</strong> 5 mg OD.</p>
                            </div>
                            <div class="grid-item">
                                <h4>Azelastine</h4>
                                <p>Topical intranasal spray. Quick relief. Also inhibits histamine release.</p>
                            </div>
                        </div>
                    </div>
                </section>

                <!-- Section 7: Therapeutic Uses -->
                <section class="content-section" id="uses">
                    <div class="section-header">
                        <div class="section-number">07</div>
                        <h2 class="section-title">
                            <span class="title-icon">üè•</span>
                            Therapeutic Uses
                        </h2>
                    </div>

                    <div class="content-card">
                        <h4>1. Allergic disorders</h4>
                        <p>Control itching, urticaria, seasonal hay fever, allergic conjunctivitis. Ineffective in bronchial asthma. Adjuvant in anaphylaxis.</p>

                        <h4>2. Other conditions involving histamine</h4>
                        <p>Insect bite, ivy poisoning.</p>

                        <h4>3. Pruritides</h4>
                        <p>Chlorpheniramine, diphenhydramine, cyproheptadine are first choice for idiopathic pruritus.</p>

                        <h4>4. Common cold</h4>
                        <p>Symptomatic relief by anticholinergic (reduce rhinorrhoea) and sedative actions.</p>

                        <h4>5. Motion sickness</h4>
                        <p>Promethazine, diphenhydramine, dimenhydrinate and meclozine have prophylactic value. Also for morning sickness and drug induced vomiting.</p>

                        <h4>6. Vertigo</h4>
                        <p>Cinnarizine is a $\mathrm{H}_{1}$ antihistamine with anti-vasoconstrictor and calcium channel blocking activity. Used in M√©ni√®re‚Äôs disease. Betahistine (histamine analogue) is also used.</p>

                        <h4>7. Preanaesthetic medication</h4>
                        <p>Promethazine (sedative + anticholinergic).</p>

                        <h4>8. Cough</h4>
                        <p>Components of cough remedies (Chlorpheniramine, Diphenhydramine).</p>

                        <h4>9. Acute muscle dystonia</h4>
                        <p>Parenteral promethazine or diphenhydramine relieves drug-induced dystonia.</p>
                    </div>
                </section>

                <!-- Problem Directed Study -->
                <section class="content-section" id="problem-study">
                    <div class="section-header">
                        <div class="section-number">08</div>
                        <h2 class="section-title">
                            <span class="title-icon">üß©</span>
                            Problem Directed Study
                        </h2>
                    </div>

                    <div class="content-card">
                        <div class="callout callout--warning">
                            <div class="callout-header">
                                <span class="callout-icon">‚ùì</span>
                                <h4 class="callout-title">Case Study 11.1</h4>
                            </div>
                            <div class="callout-content">
                                <p>A taxi driver aged 30 years presented with sudden onset running and itchy nose, bouts of sneezing, partial nasal blockage, redness and watering from the eyes. Diagnosis: Seasonal allergic rhinitis. He needs an oral antiallergic medication once a day.</p>
                                <p><strong>(a) Which antiallergic medicine would be suitable for this patient? Which antiallergic drugs should be avoided?</strong></p>
                                <p><strong>(b) Will the above medication prevent/reduce recurrent episodes of rhinitis that this patient gets during spring? If not, can some medications be added?</strong></p>
                                <p><em>(See Appendix-1 for solution).</em></p>
                            </div>
                        </div>
                    </div>
                </section>

            </main>

            <nav class="document-nav">
                <div class="nav-container">
                    <a href="topic-11-antiadrenergic.html" class="nav-button nav-button--large nav-button--previous">
                        <div class="nav-label">Previous</div>
                        <div class="nav-title">Antiadrenergic Drugs</div>
                    </a>
                    
                    <div class="document-progress">
                        <div class="progress-indicator">
                            <span>12</span>
                            <span class="progress-separator">/</span>
                            <span>13</span>
                        </div>
                        <div class="progress-bar-container">
                            <div class="progress-bar-fill" style="width: 92.3%;"></div>
                        </div>
                        <div class="progress-label">Topic Progress</div>
                    </div>
                    
                    <a href="topic-13-serotonin.html" class="nav-button nav-button--large nav-button--next">
                        <div class="nav-label">Next</div>
                        <div class="nav-title">5-HT & Migraine</div>
                    </a>
                </div>
            </nav>
        </article>
    </div>
</div>

<!-- Lightbox Modal -->
<div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
    <div class="lightbox-backdrop"></div>
    <div class="lightbox-content">
        <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
        <img class="lightbox-image" src="" alt="">
        <p class="lightbox-caption"></p>
    </div>
</div>

<script src="../js/theme.js"></script>
<script src="../js/navigation.js"></script>
<script src="../js/interactions.js"></script>
</body>
</html>
